Stockscreener 앱 받기
0.3771
6.70%
-0.0271
시간 외 거래:
.39
0.0129
+3.42%
전일 마감가:
$0.4042
열려 있는:
$0.4
하루 거래량:
511.58K
Relative Volume:
1.04
시가총액:
$22.77M
수익:
$2.29M
순이익/손실:
$-18.63M
주가수익비율:
-0.6711
EPS:
-0.5619
순현금흐름:
$-19.32M
1주 성능:
-5.61%
1개월 성능:
-5.01%
6개월 성능:
-60.81%
1년 성능:
-65.08%
1일 변동 폭
$0.365
$0.4025
1주일 범위
$0.365
$0.4799
52주 변동 폭
$0.3067
$1.11
Femasys Inc Stock (FEMY) Company Profile
명칭
Femasys Inc
전화
770-500-3910
주소
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.3771 | 24.41M | 2.29M | -18.63M | -19.32M | -0.5619 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | Laidlaw | Buy |
Femasys Inc 주식(FEMY)의 최신 뉴스
TradingKey - TradingKey
Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns - The Globe and Mail
Femasys Inc. Announces Financial Results for Quarter Ending March 31, 2026 - geneonline.com
Femasys Inc. Q1 2026 Financials: Revenue Growth, Forward-Looking Statements, and Market Strategy - Minichart
Femasys Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
FEMASYS INC 1Q 2026: Revenue $424.9K, Net income $328.6K, EPS $0— 10-Q Summary - TradingView
Non-cash gains lift Femasys (NASDAQ: FEMY) to Q1 profit amid cash strain - Stock Titan
Net income returns at Femasys (NASDAQ: FEMY) as Q1 2026 results filed - Stock Titan
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update - The Manila Times
Femasys starts birth-control trial as it expands fertility care - Stock Titan
FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan
FEMY | Femasys Inc. Common Stock Insider Trading - Quiver Quantitative
MSN Money - MSN
Femasys pushes fertility treatment into OB/GYN offices with first paid use - Stock Titan
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete - Sahm
FEMY Earnings History & Surprises | EPS & Revenue Results | FEMASYS INC (NASDAQ:FEMY) - ChartMill
Femasys Shareholders Approve Reverse Split and Financing Plans - The Globe and Mail
Femasys Inc. (NASDAQ: FEMY) sets 2026 meeting, director and auditor votes - Stock Titan
[ARS] FEMASYS INC SEC Filing - Stock Titan
Femasys (NASDAQ: FEMY) wins approval for reverse split, high-dilution notes - Stock Titan
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up - MSN
FEMY Stock Price, Quote & Chart | FEMASYS INC (NASDAQ:FEMY) - ChartMill
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026 - The Manila Times
Femasys (FEMY) Stock Jumps on Deal (+0.71%) 2026-04-18Buy Signals - Xã Thanh Hà
Femasys partners with AMI Technologies for Israel market entry By Investing.com - Investing.com India
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio - Sahm
Femasys (FEMY) Forms Partnership with AMI Technologies to Expand Fertility Portfolio - GuruFocus
Femasys partners with AMI Technologies for Israel market entry - Investing.com
Weekly Trades: Is Femasys Inc stock undervalued right now2026 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
Is Femasys (FEMY) Stock Breaking Out | Price at $0.40, Up 0.76%Elite Trading Signals - UBND thành phố Hải Phòng
Femasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share Sale - MSN
Market Rankings: Can Femasys Inc sustain its profitabilityBond Market & Fast Moving Stock Trade Plans - baoquankhu1.vn
What is market pressure on Femasys (FEMY) Stock | Price at $0.39, Down 1.32%Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
Femasys (NASDAQ: FEMY) targets reverse split and dilutive note, warrant share issuances - Stock Titan
Can Femasys Inc grow without external funding2026 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Femasys appoints John Canning as COO - MSN
Femasys Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Lake Street Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Femasys names John Canning as chief operating officer By Investing.com - Investing.com South Africa
Femasys Names John Canning as New Chief Operating Officer - The Globe and Mail
FEMASYS (FEMY) COO awarded 150,000 stock options at $0.38 exercise price - Stock Titan
Femasys (FEMY) COO John Canning discloses ownership of 30,000 shares - Stock Titan
Femasys Inc. Appoints John Canning as Chief Operating Officer, Effective March 30, 2026 - marketscreener.com
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth - bitget.com
Femasys names John Canning as chief operating officer - Investing.com
Femasys names John Canning as Chief Operating Officer - TradingView
Veteran MedTech leader John Canning joins Femasys (NASDAQ: FEMY) as COO - Stock Titan
Femasys Inc (FEMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):